108 related articles for article (PubMed ID: 19791309)
1. [Epidemiological study on PET cancer screening].
Senda M; Inoue T; Uno K; Jinnouchi M; Tsukamoto E; Terauchi T; Nakajima R; Nishizawa S; Minamimoto R; Yoshida T
Kaku Igaku; 2009 Jun; 46(2):100-2. PubMed ID: 19791309
[No Abstract] [Full Text] [Related]
2. Who wants cancer screening with PET? A contingent valuation survey in Japan.
Yasunaga H
Eur J Radiol; 2009 Apr; 70(1):190-4. PubMed ID: 18093777
[TBL] [Abstract][Full Text] [Related]
3. [Tutelage use of positron emission tomography (PET): difficulties and controversies].
Gómez Fernández I; Almoguera Arias I; Alonso Farto JC; Durán Barquero C; Ramos Moreno E; Domínguez Montero P; Bittini Copano A; Pérez Vázquez JM
Rev Esp Med Nucl; 2004; 23(6):429-33. PubMed ID: 15625063
[No Abstract] [Full Text] [Related]
4. Cancer screening with FDG-PET.
Ide M
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):23-7. PubMed ID: 16557201
[TBL] [Abstract][Full Text] [Related]
5. The efficiency of healthcare facilities providing PET cancer screening in Japan.
Liu X
Jpn J Radiol; 2012 Apr; 30(3):198-205. PubMed ID: 22190073
[TBL] [Abstract][Full Text] [Related]
6. PET and TNM: evolution or revolution?
Cheow HK; Mikhaeel NG; O'Doherty MJ
Nucl Med Commun; 2006 Feb; 27(2):101-3. PubMed ID: 16404221
[No Abstract] [Full Text] [Related]
7. Molecular Breast Imaging and the 2016 Update to the ACR Appropriateness Criteria for Breast Cancer Screening.
Covington MF; Rhodes DJ; Pizzitola VJ
J Am Coll Radiol; 2016 Dec; 13(12 Pt A):1408. PubMed ID: 27916107
[No Abstract] [Full Text] [Related]
8. Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: based on a Japanese Nationwide Survey.
Minamimoto R; Senda M; Terauchi T; Jinnouchi S; Inoue T; Iinuma T; Inoue T; Ito K; Iwata H; Uno K; Oku S; Oguchi K; Tsukamoto E; Nakashima R; Nishizawa S; Fukuda H; Murano T; Yoshida T
Ann Nucl Med; 2011 Jan; 25(1):45-54. PubMed ID: 20953985
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncology.
Larson SM; Schwartz LH
J Nucl Med; 2006 Jun; 47(6):901-3. PubMed ID: 16741296
[No Abstract] [Full Text] [Related]
10. [Approved indications of the positron emission tomography (PET) in Spain: controlled use].
Carreras Delgado JL
An R Acad Nac Med (Madr); 2002; 119(4):655-61; discussion 687-731. PubMed ID: 16773806
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of fluorine-18 fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera.
Andrieux A; Switsers O; Chajari MH; Jacob JH; Delozier T; Gervais R; Allouache N; Laurençon V; Henry-Amar M; Bardet S
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):68-77. PubMed ID: 16557206
[TBL] [Abstract][Full Text] [Related]
12. Standards for PET image acquisition and quantitative data analysis.
Boellaard R
J Nucl Med; 2009 May; 50 Suppl 1():11S-20S. PubMed ID: 19380405
[TBL] [Abstract][Full Text] [Related]
13. FDG PET/CT in oncology: "raising the bar".
Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF
Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652
[TBL] [Abstract][Full Text] [Related]
14. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey.
Minamimoto R; Senda M; Uno K; Jinnouchi S; Iinuma T; Ito K; Okuyama C; Oguchi K; Kawamoto M; Suzuki Y; Tsukamoto E; Terauchi T; Nakashima R; Nishio M; Nishizawa S; Fukuda H; Yoshida T; Inoue T
Ann Nucl Med; 2007 Nov; 21(9):481-98. PubMed ID: 18030580
[TBL] [Abstract][Full Text] [Related]
15. Radiation exposure and risk-benefit analysis in cancer screening using FDG-PET: results of a Japanese nationwide survey.
Murano T; Minamimoto R; Senda M; Uno K; Jinnouchi S; Fukuda H; Iinuma T; Tsukamoto E; Terauchi T; Yoshida T; Oku S; Nishizawa S; Ito K; Oguchi K; Kawamoto M; Nakashima R; Iwata H; Inoue T
Ann Nucl Med; 2011 Nov; 25(9):657-66. PubMed ID: 21720777
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography and colorectal cancer.
Lin M; Wong K; Ng WL; Shon IH; Morgan M
Crit Rev Oncol Hematol; 2011 Jan; 77(1):30-47. PubMed ID: 20619671
[TBL] [Abstract][Full Text] [Related]
17. [A research group report of the standardization guideline of PET image].
Fujino K
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2005 Jan; 61(1):42-54. PubMed ID: 15682029
[No Abstract] [Full Text] [Related]
18. Detection of thyroid cancer by an FDG-PET cancer screening program: a Japanese nation-wide survey.
Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
Anticancer Res; 2014 Aug; 34(8):4439-45. PubMed ID: 25075083
[TBL] [Abstract][Full Text] [Related]
19. A brief review of Japanese guidelines for the clinical use of (18)F-FDG-PET/MRI 2012 (Ver 1.0).
Kaneta T
Ann Nucl Med; 2013 May; 27(4):309-13. PubMed ID: 23508379
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography as an imaging biomarker.
Weber WA
J Clin Oncol; 2006 Jul; 24(20):3282-92. PubMed ID: 16829652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
